EXHIBIT 1.1 FORM OF UNDERWRITING AGREEMENT 6,000,000 Shares TULARIK INC. Common Stock UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • March 3rd, 2000 • Tularik Inc • Services-commercial physical & biological research • New York
AGREEMENT ---------Indemnification Agreement • October 15th, 1999 • Tularik Inc • Delaware
U.S. UNDERWRITING AGREEMENT ---------------------------Underwriting Agreement • December 9th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
WitnessethLicense Agreement • August 11th, 2000 • Tularik Inc • Services-commercial physical & biological research • California
TULARIK INC.Registration Rights Agreement • October 15th, 1999 • Tularik Inc • California
b) As an appurtenance to Tenant's leasing of the Initial Building pursuant to Section 1.1(a), Landlord hereby grants to Tenant, for the benefit of Tenant and its employees, suppliers, shippers, customers and invitees, during the term of this Lease,...Tularik Inc • October 15th, 1999 • California
TULARIK INC. and WELLS FARGO BANK MINNESOTA, N.A. as Rights Agent RIGHTS AGREEMENT Dated as of December 11, 2002Rights Agreement • December 13th, 2002 • Tularik Inc • Pharmaceutical preparations • Delaware
THIS RIGHTS AGREEMENT ("Agreement"), dated as of December 11, 2002, between TULARIK INC., a Delaware corporation (the "Company"), and WELLS FARGO BANK MINNESOTA, N.A. ("Rights Agent").
Exhibit 99.3 It Is Unlawful To Consummate A Sale Or Transfer Of This Security, Or Any Interest Therein, Or To Receive Any Consideration Therefor, Without The Prior Written Consent Of The Commissioner Of Corporations Of The State Of California, Except...Tularik Inc • February 14th, 2000 • Services-commercial physical & biological research
Exhibit 10.6 AMENDMENT NO. 1 TO COLLABORATION AGREEMENT BETWEEN TULARIK INC. AND SUMITOMO PHARMACEUTICALS CO., LTD THIS AMENDMENT NO. 1 (this "Amendment") to the Collaboration Agreement dated as of January 31, 1995 (the "Collaboration Agreement") by...Collaboration Agreement • October 15th, 1999 • Tularik Inc • California
WitnessethOption Agreement • August 11th, 2000 • Tularik Inc • Services-commercial physical & biological research • California
TULARIK INC.Tularik Inc • December 7th, 1999 • Services-commercial physical & biological research • New York
AGREEMENT ---------Agreement • October 15th, 1999 • Tularik Inc
Tularik Inc. 6,000,000 Shares Common Stock ($0.001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2003 • Tularik Inc • Pharmaceutical preparations • New York
Tularik Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”) an aggregate of 6,000,000 shares and, at the election of the Underwriters, up to an additional 900,000 shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company. The aggregate of 6,000,000 shares to be sold by the Company is herein called the “Firm Shares” and the aggregate of 900,000 additional shares to be sold by the Company is herein called the “Optional Shares.” The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 1 hereof are herein collectively called the “Shares.” The Shares are described in the Prospectus which is referred to below.
EXHIBIT 10.17 STOCK PURCHASE AGREEMENT This Agreement is made by and between Tularik Inc., a California corporation (the "Company"), and the 1987 Swanson Family Trust ("Purchaser"). 1. Purchase of Shares. Purchaser agrees to purchase from the Company,...Stock Purchase Agreement • October 15th, 1999 • Tularik Inc
Exhibit 10.11 LICENSE AGREEMENT I. BACKGROUND This Agreement is entered into this 3/rd/ day of October 1997 by and between COLD SPRING HARBOR LABORATORY ("Licensor" or "CSHL"), a non-profit research institution located in Cold Spring Harbor, New York;...Tularik Inc • December 9th, 1999 • Services-commercial physical & biological research • New York
EXHIBIT 10.25 AGREEMENT AND GENERAL RELEASE ----------------------------- Tularik Inc., Two Corporate Drive, San Francisco, CA 94080, its affiliates, subsidiaries, divisions, successors and assigns and the employees, officers, directors and agents...Agreement and General • October 15th, 1999 • Tularik Inc • California
Exhibit 10.7 AMENDMENT NO. 2 TO RESEARCH, COLLABORATION AND LICENSE/DEVELOPMENT AGREEMENT BETWEEN TULARIK INC. AND TAISHO PHARMACEUTICAL CO., LTD. THIS AMENDMENT NO. 2 (this "Amendment") to the Research, Collaboration and License/Development Agreement...Development Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • Tokyo
Exhibit 10.14 September 20, 1998 Mr. Masakazu Kakei Executive Director and Member of Board Japan Tobacco Inc. JT Building, 2-1 Toranomon, 2-chome Minato- ku, Tokyo 105-8422, Japan Re: Preliminary Research, Development and Marketing Agreement between...Tularik Inc • December 21st, 1999 • Services-commercial physical & biological research • California
Exhibit 10.8 AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • California
Exhibit 10.11 LICENSE AGREEMENT I. BACKGROUND This Agreement is entered into this 3/rd/ day of October 1997 by and between COLD SPRING HARBOR LABORATORY ("Licensor" or "CSHL"), a non-profit research institution located in Cold Spring Harbor, New York;...Tularik Inc • December 17th, 1999 • Services-commercial physical & biological research • New York
2.2 Early Possession. Tenant shall have the nonexclusive right to occupy ---------------- and take possession of the Phase II Site from and after the date of Landlord's delivery of the Structural Completion Certificate described in clause (i) of...Suit Lease • October 15th, 1999 • Tularik Inc • California
RECITALSLicensing Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
Exhibit 10.11 LICENSE AGREEMENT I. BACKGROUND This Agreement is entered into this 3/rd/ day of October 1997 by and between COLD SPRING HARBOR LABORATORY ("Licensor" or "CSHL"), a non-profit research institution located in Cold Spring Harbor, New York;...Tularik Inc • October 27th, 1999 • Services-commercial physical & biological research • New York
betweenCollaboration Agreement • December 9th, 1999 • Tularik Inc • Services-commercial physical & biological research • California
Exhibit 10.10 RESEARCH AGREEMENT Research Agreement between Cold Spring Harbor Laboratory, hereinafter referred to as "CSHL," and Tularik Inc., hereinafter referred to as "Sponsor". This Agreement is entered into as of October 3, 1997 and will be...Research Agreement • December 17th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
AGREEMENT AND PLAN OF MERGER BY AND AMONG AMGEN INC., ARROW ACQUISITION, LLC AND TULARIK INC. DATED AS OF MARCH 28, 2004Agreement and Plan of Merger • March 30th, 2004 • Tularik Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER, dated as of March 28, 2004 (this “Agreement”), by and among AMGEN INC., a Delaware corporation (“Parent”), ARROW ACQUISITION, LLC, a Delaware limited liability company wholly-owned by Parent (“Merger Sub”), and TULARIK INC., a Delaware corporation (the “Company”).
EXHIBIT 10.19 SUBLEASETularik Inc • October 15th, 1999
RecitalsScreening Agreement • December 9th, 1999 • Tularik Inc • Services-commercial physical & biological research • New York
Exhibit 4.3 TULARIK INC. INVESTOR RIGHTS AGREEMENT October 31, 1997 TABLE OF CONTENTSRights Agreement • October 15th, 1999 • Tularik Inc • Delaware
SUBLEASESublease • October 15th, 1999 • Tularik Inc
SUBLEASETularik Inc • October 15th, 1999
STOCKHOLDER VOTING AGREEMENT BY AND BETWEEN AMGEN INC. and The Stockholders Identified on Schedule A attached hereto Dated as of March 28, 2004Stockholder Voting Agreement • March 30th, 2004 • Tularik Inc • Pharmaceutical preparations • Delaware
This STOCKHOLDER VOTING AGREEMENT (this “Agreement”) is entered into as of March 28, 2004, by and among Amgen Inc., a Delaware corporation (“Parent”), and the Stockholders of Tularik Inc., a Delaware corporation (the “Company”) identified on Schedule A attached hereto (each a “Stockholder” and collectively, the “Stockholders”).
CONSULTING AGREEMENTConsulting Agreement • August 14th, 2002 • Tularik Inc • Pharmaceutical preparations • California
THIS AGREEMENT is made by and between Tularik Inc., a Delaware corporation (the “Company”), and Craig A.P.D. Saxton, M.D. (“Consultant”), effective April 18, 2002 for the purpose of setting forth the terms and conditions by which the Company will acquire Consultant’s services on a temporary basis.
AMENDMENT TO RIGHTS AGREEMENT BETWEEN TULARIK INC. AND WELLS FARGO BANK MINNESOTA, N.A.Rights Agreement • November 12th, 2003 • Tularik Inc • Pharmaceutical preparations • Delaware
THIS AMENDMENT TO RIGHTS AGREEMENT (the “Amendment”) is made this 10th day of November, 2003, by and between TULARIK INC., a Delaware corporation (the “Company”), and WELLS FARGO BANK MINNESOTA, N.A. (the “Rights Agent”).
AMENDMENT NO. 1 TO LICENSING AGREEMENT BETWEEN TULARIK INC. AND ELI LILLY AND COMPANYTularik Inc • August 13th, 2001 • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (this "Amendment") to the Licensing Agreement dated as of September 30, 1999 (the "Agreement") by and between Eli Lilly And Company, an Indiana corporation, having offices at Lilly Corporate Center, Indianapolis, Indiana 46285 ("Lilly"), and Tularik Inc., a Delaware corporation having offices at Two Corporate Drive, South San Francisco, California 94080 ("Tularik"), is entered into as of January 10, 2001. Lilly and Tularik may be referred to herein individually as a "Party" or, collectively, as "Parties".
